Journal article · 2026 · Open access
Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300
The Journal of Experimental Medicine, 223(11), e20251898 · Published 20 October 2026 · DOI 10.1084/jem.20251898
In brief
“Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300” is a 2026 journal article by Ian Michael Delahunty and 32 co-authors, published in The Journal of Experimental Medicine. OpenAlex counts 0 citations as of 17 November 2026. It is open access under a CC BY licence: the full text is free to read at The Journal of Experimental Medicine.
- Citations
- 0
- References
- 86
- Authors
- 33
Abstract
Cancers depend on transcriptional control to maintain the malignant cell state. EP300 and CBP are paralogous master epigenetic enzymes that control normal and malignant transcription. Using a cancer-wide integrative chemical-genetic analysis, we demonstrate enhanced dependency on EP300, compared with CBP, in cell lines from most cancer lineages, including lethal osteosarcoma (OS). Using a selective EP300 degrader (JQAD1), we identify that a genetically defined subgroup of OS with dysregulation of the PI3K-AKT-mTOR pathway is genetically and chemically sensitive to loss of EP300. Activated AKT promotes sensitivity to JQAD1, driven by relocalization of EP300, CBP and H3K27ac to genetic subtype-enriched dependency loci. AKT inhibition combines with JQAD1 to synergistically suppress the growth of AKT-dysregulated OS cells in vitro and in orthotopic xenografts. These observations extend across >850 cancer cell lines, where synergy is predicted by elevated protein synthetic rates. These findings reveal determinants of EP300 degrader function in OS and provide a foundation for co-targeting EP300 and AKT in cancers with enhanced protein translation.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Delahunty, I. M., Nance, S., Zhang, Y., Lamoureux, F., Liu, Q., Wright, W. C., Ritter, K., Shendy, N. A., Royer, B. B.-L., Kietlinska, S. J., Nezhady, M. A. M., Feng, Y., De Kegel, B., Rees, M. G., Kocak, M., George, A. B., Lu, M., Kavirayani, A. M., Wang, B., . . . Durbin, A. D. (2026). Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300. The Journal of Experimental Medicine, 223(11), e20251898. https://doi.org/10.1084/jem.20251898
MLA 9
Delahunty, Ian Michael, et al. “Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300.” The Journal of Experimental Medicine, vol. 223, no. 11, 2026, p. e20251898. https://doi.org/10.1084/jem.20251898.
Chicago
Delahunty, Ian Michael, Stephanie Nance, Yang Zhang, François Lamoureux, Qi Liu, William C. Wright, Kristina Ritter, et al. 2026. “Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300.” The Journal of Experimental Medicine 223 (11): e20251898. https://doi.org/10.1084/jem.20251898.
Harvard
Delahunty, I. M. et al. (2026) ‘Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300’, The Journal of Experimental Medicine, 223(11), p. e20251898. doi:10.1084/jem.20251898.
IEEE
I. M. Delahunty et al., “Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300,” The Journal of Experimental Medicine, vol. 223, no. 11, p. e20251898, 2026, doi: 10.1084/jem.20251898.
BibTeX
@article{delahunty2026dysregulated,
title = {{Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300}},
author = {Delahunty, Ian Michael and Nance, Stephanie and Zhang, Yang and Lamoureux, François and Liu, Qi and Wright, William C. and Ritter, Kristina and Shendy, Noha A.M. and Royer, Bénédicte Brounais-Le and Kietlinska, Sandra J. and Nezhady, Mohammad Ali Mohammad and Feng, Yuan and De Kegel, Barbara and Rees, Matthew G. and Kocak, Mustafa and George, Ashish Bino and Lu, Meifen and Kavirayani, Anoop Murthy and Wang, Bo and Liu, Yanling and Prinsen, Paris E.A. and Khashana, Yousef and Ebegboni, Vernon Justice and Ronan, Melissa M. and Roth, Jennifer A. and Sweet-Cordero, Alejandro and Guenther, Lillian M. and Geeleher, Paul and Ma, Xiaotu and Ory, Benjamin and others},
journal = {The Journal of Experimental Medicine},
year = {2026},
volume = {223},
number = {11},
pages = {e20251898},
doi = {10.1084/jem.20251898},
url = {https://doi.org/10.1084/jem.20251898}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- osteosarcoma
- EP300
- CBP
- Akt signaling
- PI3K/AKT/mTOR pathway
- H3K27ac
- transcriptional dependency
- synthetic lethality
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Delahunty, I. M., Nance, S., Zhang, Y., Lamoureux, F., Liu, Q., Wright, W. C., Ritter, K., Shendy, N. A., Royer, B. B.-L., Kietlinska, S. J., Nezhady, M. A. M., Feng, Y., De Kegel, B., Rees, M. G., Kocak, M., George, A. B., Lu, M., Kavirayani, A. M., Wang, B., . . . Durbin, A. D. (2026). Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300. The Journal of Experimental Medicine, 223(11), e20251898. https://doi.org/10.1084/jem.20251898
How many times has this paper been cited?
0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at The Journal of Experimental Medicine: sign in and open the PDF from this page.
Who wrote this paper?
Ian Michael Delahunty, Stephanie Nance, Yang Zhang, François Lamoureux, Qi Liu, William C. Wright, Kristina Ritter, Noha A.M. Shendy, Bénédicte Brounais-Le Royer, Sandra J. Kietlinska, Mohammad Ali Mohammad Nezhady, Yuan Feng and 21 more.
What is the DOI of this paper?
10.1084/jem.20251898, permanently at https://doi.org/10.1084/jem.20251898. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.